Year-over-year net earnings per share growth for the last 12 months: Catalent Inc. (CTLT)

CTLT (Catalent Pharma Solutions) - company brandmark

Catalent, Inc. (CTLT) maintains immense customer loyalty due to its status as a global leader in contract manufacturing, as evidenced by the quarterly EPS trend on the GURU.Markets chart, where the 0.00 level defines this metric. However, geopolitical control over raw materials creates risks, while capacity restructuring costs are temporarily limiting the business's operational efficiency.

catalent.com (CTLT) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 01/04/2025

CTLT (Catalent, Inc): analytical breakdowns and indicator data

- market value and analyst target forecast:
Price Chart Catalent|CTLT - Analyst Median Target
- company stock exchange capitalization indicators:
Market Valuation Catalent Pharma Solutions|CTLT - Aggregate Business Value
- book capitalization indicators:
Net Assets per Single Share Catalent|CTLT - Book Valuation of Business|Market Capitalization to Book Value Ratio catalent.com|CTLT - Cumulative Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital Catalent, Inc.|CTLT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Catalent, Inc.|CTLT - Company Cumulative Indebtedness|Debts to Book Capitalization Catalent Pharma Solutions|CTLT - Company Long-Term Debts|Company Short-Term Debt Catalent|Quick Ratio catalent.com
- earnings and market multiples details:
CTLT - Company Net Income|Expected Profit Catalent, Inc.|CTLT - Price to Earnings Multiple|Projected Price to Earnings Catalent Pharma Solutions|CTLT - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio Catalent Pharma Solutions|CTLT - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Catalent|CTLT - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months catalent.com|CTLT - Earnings per share growth this year|Earnings growth forecast for next year Catalent, Inc.
- sales and revenue data:
CTLT - Company Sales|Company Future Sales Volume Catalent|CTLT - Price-to-Revenue Coefficient|Forward P/S Multiple Catalent Pharma Solutions
Fundamental company valuation:Catalent - CTLT
Flagship merchandise of catalent.com

Professional asset selection is based on identifying hidden financial imbalances through an analysis of real net profit dynamics. This quarterly percentage growth in earnings per share measures the rate of change in EPS while excluding accounting distortions, confirming the operational resilience of Catalent, Inc. (CTLT) as an indispensable CDMO leader with colossal barriers to entry and strict government regulation.

Competitor analysis

IQVIA (IQV) - Year-over-year earnings per share growth for the last twelve months|LH - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months MEDP|ICLR (iconplc.com) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Charles River Laboratories (CRL)|Year-over-year net earnings per share change for the last twelve months evotec.com|Quarterly EPS earnings growth FTRE (Fortrea)|LFCR - Year-over-year net earnings per share growth for the last 12 months|OmniAb Corp - Quarterly EPS earnings growth|NOTV - Quarterly EPS earnings growth|CDMO (Avid Bioservices, Inc.) - Year-over-year net earnings per share growth for the last 12 months|SCPX: Year-over-year earnings per share growth rate for the last twelve months